Lower PSA Screening Rates Linked to Rise in Mets Prostate Cancer
-
Veterans Administration (VA) medical centers with lower prostate-specific antigen (PSA) screening rates reported higher rates of metastatic prostate cancer, a recent retrospective analysis found. Across 128 VA facilities, PSA screening rates fell from 47.2% in 2005 to 37% in 2019, while metastatic prostate cancer incidence increased from 5.2 per 100,000 to 7.9 per 100,000 men in that time.
-
@sajjan The current study is "very important because it showed that in groups of patients where screening was not encouraged or not practiced, we saw an increase in patients presenting with late stages of prostate cancer," said Jeff M. Michalski, MD, MBA, president-elect of the American Society for Radiation Oncology (ASTRO), at a press briefing.